Search This Blog

Tuesday, August 7, 2018

PTC Therapeutics reports Q2 EPS (21c), consensus (29c)


Reports Q2 revenue $68.7M, consensus $65.7M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.